Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Pfizer's Cannabinoid-Related Biotech Company Arena's Q4 Net Loss Grows 27% YoY

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) revealed Wednesday financial results for the fourth quarter and full year ended Dec. 31, 2021. Q4 Finanical HIghlights

Benzinga

Will you need a 2nd booster shot to keep coronavirus at bay?

With omicron fading and pressure growing to ease mask rules and other pandemic restrictions, there is growing debate among health officials and experts about if or when a second booster shot will be part of this path toward recovery.

Los Angeles Times

CDC: Some people should wait longer for 2nd COVID shot

U.S. health officials say some people getting Pfizer or Moderna COVID-19 vaccines should consider waiting up to eight weeks between the first and second doses

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Covid live: Poland, Slovakia and Iceland latest countries set to end most coronavirus restrictions — as it happened

Move comes as case numbers and deaths continue to fall in many nations

The Guardian - UK

The Moderna vaccine is now available for 6 to 11 year olds. Here's what parents need to know

Australian children aged six to 11 years old will be able to get the Moderna COVID vaccine at pharmacies, GP clinics and vaccination hubs from tomorrow.

The Conversation

S. Korea approves Pfizer's COVID vaccine for ages 5-11

South Korean health officials have approved Pfizer’s COVID-19 vaccine for children aged 5 to 11, expanding the country's immunization program in the face of a massive omicron outbreak that is driving up hospitalizations and deaths

The Independent UK

Moderna COVID-19 vaccine approved for six- to 11-year-old children

Children aged six to 11 years can get a Moderna COVID-19 vaccine from tomorrow, after it was given the final green light.

ABC News

Read news from The Economist, FT, and more,
with one subscription

Do COVID boosters cause more or fewer side effects? How quickly does protection wane? Your questions answered

The Australian Technical Advisory Group on Immunisation (ATAGI) recommends Australians aged 16 years and older have a COVID booster vaccine three months after receiving their second dose.

The Conversation

Mayo Clinic expert stresses importance of vaccinating school-age children for COVID-19

Parents hoping to get their young children vaccinated for COVID-19 will have to wait at least another two months. The Food and Drug Administration (FDA) recently postponed a decision on an emergency use authorization of the Pfizer vaccine for kids 6 months to 4 years old. The FDA is waiting…

Tribune News Service

Germany to begin rollout of Novavax’s jab; New Zealand to end vaccine mandates after Omicron peak

Latest updates: Germany hopes protein-based vaccine comparable to flu jabs will help sway people sceptical of mRNA vaccines

The Guardian - UK

Egypt to Receive New Batches of Pfizer Covid Vaccines

Health Ministry Spokesman Hossam Abdel Ghaffar said Egypt is set to receive a new shipment containing 2,158,650 doses of the Pfizer coronavirus vaccine. In statements to the MENA news agency on Saturday, the spokesman added that the shipment is part of the state’s plan to provide various kinds of vaccines…

Asharq Al-Awsat

The Federal Tap: Congressman Jim Hagedorn (R) passes away

Our weekly summary of federal news updates you on Congressman Jim Hagedorn’s (R) recent death and the newest congressional districts in Minnesota. Read all about it in this week’s edition of the Federal Tap.

Ballotpedia

Vaccine side effects very rare, says DDC

Few side effects have been reported among the 120 million Covid-19 vaccine doses administered, according to the Department of Disease Control (DDC).

Bangkok Post

Covid: South Korea reports more than 100,000 new cases for first time – as it happened

Latest updates: south Korean case numbers have risen in recent weeks due to Omicron

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Caixin Global

Opinion: China Has Approved Pfizer’s Covid Drug. What’s Next?

The government now needs to place an order and set a delivery schedule, given the limited supply

McClatchy Washington Bureau

FDA says official suggesting annual COVID vaccines ‘does not work on vaccine matters’

A video has emerged of a Food and Drug Administration executive suggesting there are plans for annual COVID-19 vaccines to be implemented in the United States.

Benzinga

Pfizer/BioNTech's Omicron-Targeted COVID-19 To Miss March Timeline: Reuters

Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) omicron-targeted COVID-19 vaccine is delayed by several weeks due to a slower-than-expected data gathering process,

Daily Mirror

Can my child have the Covid vaccine – and what are the side effects?

The Covid vaccine programme has been extended further to include children aged five to 11 without underlying health conditions, in a bid to protect against potential future waves of Covid-19

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart

Macy's Inc (NYSE: M) retail stores have something for everyone in the family, and over the past year, has returned unmistakable gains for bullish traders and investors.

Tribune News Service

‘Game changer’ Pfizer pill is easier to find as omicron fades away

As the omicron wave peaked in the U.S. last month, the first-line treatment for high-risk patients with early COVID-19 dangled out of reach for most. Only a trickle of the new Paxlovid pill from Pfizer Inc. was reaching hospitals and pharmacies.

Investors Business Daily

Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?

Biotech stocks are down and out right now. But sentiment can turn on a dime. Here are trends to watch in the biotech sector in 2022.

Benzinga

This Is What Whales Are Betting On Pfizer

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 25 strange trades.

The Guardian - UK

Five- to 11-year-old children in England to be offered Covid vaccine

Pfizer/BioNTech jab to be offered to younger children as experts decide benefits outweigh risks

The Guardian - UK

Germany and Switzerland set to ease restrictions – as it happened

This blog is now closed.

The Independent UK

Vaccinated people less likely to get long Covid than unvaccinated, new study shows

Review finds those who have received two doses of Pfizer/BioNTech, AstraZeneca or Moderna vaccine, or one dose of single-shot J&J vaccine, half as likely to develop long Covid symptoms

1 … 64 65 66 67

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

World Health Organization

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.